-
Diagnostics World News | What’s next for Biogen and Eisai; COVID updates from Thermo Fisher, New England Biolabs, and OraSure; new products from QIAGEN, InterVenn, Nuvo Group and more.
Jun 29, 2021
-
Diagnostics World News | Only about a quarter of anesthesiologists delivering anesthesia to patients during surgery are monitoring unconsciousness using electroencephalography (EEG), the recording of neural activity via electrodes on the scalp. A new company spun out of MIT and MGH hopes to change that.
Jun 23, 2021
-
Diagnostics World News | Researchers at the Mayo Clinic have demonstrated that a standard, 12-lead electrocardiogram (ECG)—supplemented with AI—can be a biomarker of biological age, and the gap relative to chronological age is an independent risk predictor of both all-cause and cardiovascular mortality. Artificial intelligence (AI) was used to predict biological age from ECGs.
Jun 21, 2021
-
Diagnostics World News | Much like other technology devices, medical equipment is getting smaller. Ultrasound machines, for example, are no longer forced to live on carts that are pushed from examination room to examination room. Many can now fit in the palm of your hand and operate through Smart Phones. While the machines no longer have the same complex look and feel, training health care professionals, who will be using these devices, correctly and accurately is absolutely paramount to quality patient care.
Jun 18, 2021
-
Diagnostics World News | Tilak Healthcare aims to combine video games with medical expertise so that the same vision monitoring tools that are reliable and useful for doctors will be playful and fun for users. If Tilak can achieve that, the company tools will be “sticky” enough to have a longstanding impact on the healthcare process for patients.
Jun 15, 2021
-
Diagnostics World News | Artificial intelligence (AI) algorithms were recently found to perform on par with pathologists when it came to quantifying tumor cellularity, an increasingly common measure of patient response to neoadjuvant therapy for breast cancer. That was one of the key findings of the Breast Pathology Quantitative Biomarkers (BreastPathQ) Challenge.
Jun 9, 2021
-
Diagnostics World News | A new public health initiative is looking to determine whether widespread access to rapid at-home antigen tests can help reduce the spread of SARS-CoV-2, the virus that causes COVID-19. Dubbed “Say Yes! COVID Test,” the initiative launched by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) is zeroing in on Pitt County, N.C., and Chattanooga/Hamilton County, Tenn.
Jun 7, 2021